Savoie Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Savoie Capital's LLY Position: Q2 2025 in Review
Savoie Capital reduced its Eli Lilly (LLY) stake by 0.53% in Q2 2025, selling an estimated $77.7K and leaving 18,816 shares worth $14.7M. The position accounts for 1.82% of the portfolio, ranked #12.
Savoie Capital first reported a position in LLY in Q3 2023 and has held it in 7 quarters since. The position peaked at $16.1M in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- Savoie Capital held 18,816 shares of Eli Lilly worth $14.7M as of Q2 2025.
- Savoie Capital sold 100 Eli Lilly shares in Q2 2025, an estimated $77.7K.
- Eli Lilly made up 1.82% of Savoie Capital's portfolio in Q2 2025, its #12 holding.
- Savoie Capital first reported a position in Eli Lilly in Q3 2023 and has held it in 7 quarters since.
- Savoie Capital's Eli Lilly position peaked at $16.1M in Q3 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on Savoie Capital's 13F filing for Q2 2025, filed 14 Aug 2025.